¿ A story in the Nov. 7, 2000, issue of BioWorld Today incorrectly stated that Emisphere Technologies Inc. and DuPont Pharmaceuticals Co. had a development and marketing agreement. The companies actually signed a non-binding letter of intent for the development and marketing of oral formulations of heparin and low-molecular-weight heparin.

¿ A news item in the Nov. 8, 2000, issue of BioWorld Today mistakenly referred to Discovery Laboratories Inc., of Doylestown, Pa., as Discovery Partners International Inc., an unrelated company in San Diego.

Editor's Note: The corrections already have been made in BioWorld Online.

No Comments